Cargando…
Remdesivir: Renal dysfunction and liver dysfunction following off-label use: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136751/ http://dx.doi.org/10.1007/s40278-022-16219-3 |
Ejemplares similares
-
Aciclovir/dexamethasone/remdesivir: Lack of efficacy following off-label use: case report
Publicado: (2022) -
Remdesivir/tocilizumab: Drug ineffective and off-label use: 2 case reports
Publicado: (2021) -
Isavuconazole/letermovir/remdesivir: Drug-induced liver injury and off-label use: case report
Publicado: (2021) -
Azithromycin/ceftriaxone/remdesivir: Bradycardia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022) -
Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)